Navigation Links
AMRI Announces Pricing of $130 Million Cash Convertible Senior Notes
Date:11/20/2013

ALBANY, N.Y., Nov. 20, 2013 /PRNewswire/ -- Albany Molecular Research, Inc. (NASDAQ: AMRI) ("AMRI") announced that it has upsized to $130.0 million principal amount and priced its previously announced private offering of cash convertible senior notes due 2018 to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). AMRI also granted the initial purchasers of the notes an option to purchase up to an additional $20.0 million principal amount of the notes solely to cover over-allotments, if any.

When issued, the notes will be unsecured senior obligations of AMRI and bear interest at a rate of 2.25% per annum, payable semi-annually on May 15 and November 15 of each year, commencing May 15, 2014. The notes will mature on November 15, 2018, unless earlier repurchased or converted into cash in accordance with their terms prior to such date. The notes will be convertible at the option of the holders only in certain circumstances and solely into cash. The notes will not be convertible into AMRI's common stock or any other security under any circumstances. AMRI will not have the right to redeem the notes prior to maturity. The conversion rate for the notes will initially be 63.9844 shares of AMRI's common stock per $1,000 principal amount of notes, which is equivalent to an initial conversion price of approximately $15.63 per share of AMRI's common stock. The initial conversion price of the notes represents a premium of approximately 32.0% to the $11.84 per share last reported sale price of AMRI's common stock on November 19, 2013. The offering of the notes is expected to close on November 25, 2013, subject to customary closing conditions.

J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC are acting as joint-bookrunning managers for the offering.

In connection with
'/>"/>

SOURCE AMRI
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Marken Announces Opening of Cold Chain Distribution Hub in Dublin, Ireland
2. Northwest Biotherapeutics Announces Proposed Public Offering Of Common Stock [and Warrants]
3. Tandem Diabetes Care Announces Closing of Initial Public Offering
4. Mylan Announces Pricing of $2.0 Billion of Senior Notes
5. Ultra Clean Announces Participation in the 2nd Annual Midtown CAP Summit Investor Conference
6. Simcere Pharmaceutical Group Announces Extraordinary General Meeting of Shareholders
7. Assurex Health Announces International Expansion through Canadian Partnership with the Centre for Addiction and Mental Health
8. PBL Assay Science announces ultra-sensitive assay services to measure biomolecules in human serum or plasma
9. Irvine Center for Clinical Research Announces Open Enrollment for New Low Testosterone Study
10. American Medical Systems Announces 500th Patient Enrolled in PROPPER Registry
11. OncoGenex Announces Update on Phase 3 SYNERGY Trial Evaluating Custirsen in Men with Metastatic Castrate-Resistant Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... NOT FOR RELEASE, PUBLICATION OR ... INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD ... SUCH JURISDICTION. AbbVie (NYSE: ABBV ) ... 25, 2014, before the market opens. AbbVie will ... 8 a.m. Central time (9 a.m. Eastern). It will be ...
(Date:7/23/2014)... 23, 2014 Research and Markets ... "Global Electrophysiology Ablation Catheters Market 2014-2018" report ... http://photos.prnewswire.com/prnh/20130307/600769 Catheter ablation is a ... faulty electrical pathways from sections of the heart ... cardiac arrhythmias). Cardiac arrhythmias can be of several ...
(Date:7/23/2014)...  Nonin Medical, Inc., the inventor of finger pulse ... today that Mark VanderWerf , Nonin,s Vice President ... the American Telemedicine Association,s (ATA) Industry Council and will ... ATA is the leading international resource and advocate promoting ... and its diverse membership work to transform healthcare to ...
Breaking Medicine Technology:AbbVie to Host Second-Quarter Earnings Conference Call 2AbbVie to Host Second-Quarter Earnings Conference Call 3AbbVie to Host Second-Quarter Earnings Conference Call 4AbbVie to Host Second-Quarter Earnings Conference Call 5AbbVie to Host Second-Quarter Earnings Conference Call 6Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 2Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 3Nonin Medical Announces that Mark VanderWerf has been Elected Chairman of the American Telemedicine Association's Industry Council 2
... Rochester Medical Implants ( http://www.rmi.us.com ), a contract manufacturer ... it has relocated corporate offices and manufacturing operations to ... the location change, the company will change its name ... The new facility is a modern 33,000-square ...
... Calif., Oct. 17, 2011 ChemoCentryx, Inc., today ... trial for CCX168, an orally-administered small molecule for ... (AAV), a disease which can lead to renal ... receptor (C5aR), a potent pro-inflammatory mediator that is ...
Cached Medicine Technology:Rochester Medical Implants Relocates to New Facility in Noblesville, IN 2ChemoCentryx Initiates Phase II Clinical Trial for CCX168, a Novel Small Molecule C5aR Antagonist for the Treatment of Vasculitis 2ChemoCentryx Initiates Phase II Clinical Trial for CCX168, a Novel Small Molecule C5aR Antagonist for the Treatment of Vasculitis 3ChemoCentryx Initiates Phase II Clinical Trial for CCX168, a Novel Small Molecule C5aR Antagonist for the Treatment of Vasculitis 4
(Date:7/23/2014)... 2014 (HealthDay News) --,Jealousy may not be the sole ... get downright possessive when it comes to the love ... toward what was actually a stuffed dog, the real ... the stuffed dog aside, report researchers from the University ... only surfaced when owners were attending to the stuffed ...
(Date:7/23/2014)... effort to catalog the molecular causes of stomach ... have identified four subtypes of tumors based on ... the new classification promises to advance clinical research ... killer worldwide. , In a report in ... Research Network said they analyzed 295 samples of ...
(Date:7/23/2014)... 2014 Texas Physical Therapy Specialists (TexPTS) ... their Westlake, Westgate, Liberty Hill, Parmer, Balcones, and Georgetown ... of Orthopaedic Certified Specialist (OCS) or ... PT, DPT, OCS, Tony Lauretta, PT, DPT, OCS, Jason ... Joseph Leech, PT, DPT, OCS, and Mary Grimberg, PT, ...
(Date:7/23/2014)... A therapy combining salmon fibrin injections into the spinal ... brain restored voluntary motor function impaired by spinal cord ... found. , In a study on rodents, Gail Lewandowski ... the developmental clock in a molecular pathway critical to ... a scaffold so that neuronal axons at the injury ...
(Date:7/23/2014)... North American market was valued at $985.4 million in 2012. ... 10.79%, to reach $1,801.1 million by 2018. Organobromines is the ... Bromine Market report defines and segments the bromine market in ... the TOC of the North American Bromine Market report, to ... provides a glimpse of the segmentation in the North America ...
Breaking Medicine News(10 mins):Health News:Dogs Can Get Jealous, Too 2Health News:New view of stomach cancer could hasten better therapies 2Health News:New view of stomach cancer could hasten better therapies 3Health News:Texas Physical Therapy Specialists Congratulates New Board Certified Specialists 2Health News:Texas Physical Therapy Specialists Congratulates New Board Certified Specialists 3Health News:Gene inhibitor, salmon fibrin restore function lost in spinal cord injury 2Health News:North America Bromine Market is Expected to Reach $1801.1 million in 2018 - New Report by MicroMarket Monitor 2Health News:North America Bromine Market is Expected to Reach $1801.1 million in 2018 - New Report by MicroMarket Monitor 3Health News:North America Bromine Market is Expected to Reach $1801.1 million in 2018 - New Report by MicroMarket Monitor 4
... ... drug efficacy and reducing side effects , ... Santa Barbara, Calif. (Vocus) April 8, 2010 -- Researchers have ... penetrate deeply into tumor tissue. The peptide has been shown to substantially increase treatment ...
... effective as blood thinner, study finds , THURSDAY, April 8 ... works as well as medication -- and is safer -- ... device is as useful as blood thinners for the reduction ... safety," said study co-author Dr. Douglas E. Padgett, chief of ...
... have resulted in extended and repeated combat-related deployments of U.S. ... problems, both physical and psychological, many bring back with them, ... home can have issues as well. The ... quickly adjust to altered family roles and the stress of ...
... can take in the waiting room may lead to ... News) -- A researcher has developed a brief ... suffering from the early memory and reasoning problems that ... the journal Alzheimer Disease and Associated Disorders , ...
... under Singapore,s Agency for Science, Technology and Research (A*STAR), ... (SIgN), are collaborating with Italy,s Siena Biotech S.p.A. to ... potentially help millions of cancer and bone loss patients ... collaboration A*STAR has with research centres and universities in ...
... others interested in the chemical sciences are invited to ... Society (ACS) Webinars, focusing on Professional Growth and Development. ... p.m. Eastern Time, the free webinar will feature Martin ... years of experience working on immigration visas for scientists, ...
Cached Medicine News:Health News:Research Reveals Cancer Drug Effectiveness Substantially Advanced 2Health News:Research Reveals Cancer Drug Effectiveness Substantially Advanced 3Health News:Research Reveals Cancer Drug Effectiveness Substantially Advanced 4Health News:Research Reveals Cancer Drug Effectiveness Substantially Advanced 5Health News: Compression Device May Outperform Meds After Hip Surgery 2Health News:Children of combat-deployed parents show increased worries, even after parent returns 2Health News:Simple Memory Test May Detect Early Alzheimer's 2Health News:Exploring the 'Davids and Goliaths' of therapeutic molecules 2Health News:Exploring the 'Davids and Goliaths' of therapeutic molecules 3Health News:ACS Webinar focuses on immigration law for scientific professionals 2
300 L, Bulk Recommended for 250 and 300 L pipettes. Can also be used with 20, 25, 50, 100 and 200 L pipette...
Its MicroPoint design and reference marks at 10, 50 and 100 L ensure accurate performance with a variety of multi-channel and single-channel pipettors....
... its wide orifice tip, the Finntip Wide ... suspensions and macromolecules like genomic DNA. This ... cell fragmentation. It is excellent for use ... model, the inside diameter of the orifice ...
MBP's equivalent to the "Universal Yellow" tip, this 200 ul tip utilizes a MicroPoint design for accurate sample handling. 10 L Ref. mark....
Medicine Products: